CD274 and neoplasm: Notably, BBIT20 treatment resulted in a reduction in PD-L1 staining intensity (Fig. 8E and Q), suggesting a potential reactivation of the tumour immune response to recognize and destroy tumour cells, thereby restoring effective antitumor immune responses [61].